| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 197 | 204.466 | 230.413 | 320.504 | 330.524 |
| Total Income - EUR | - | - | - | - | - | 197 | 204.466 | 230.413 | 321.255 | 337.957 |
| Total Expenses - EUR | - | - | - | - | - | 2.044 | 43.682 | 87.518 | 120.173 | 125.000 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -1.847 | 160.784 | 142.894 | 201.082 | 212.957 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.847 | 158.080 | 140.674 | 198.347 | 203.322 |
| Employees | - | - | - | - | - | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Dermalis By Dr Riciu S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 11.187 | 120.616 | 82.761 | 88.600 | 242.817 |
| Current Assets | - | - | - | - | - | 3.979 | 115.017 | 109.239 | 167.689 | 136.484 |
| Inventories | - | - | - | - | - | 3.775 | 10.952 | 15.225 | 15.213 | 16.852 |
| Receivables | - | - | - | - | - | 0 | 833 | 90.144 | 1 | 116.292 |
| Cash | - | - | - | - | - | 204 | 103.232 | 3.870 | 21.069 | 3.341 |
| Shareholders Funds | - | - | - | - | - | -1.806 | 156.314 | 140.715 | 222.405 | 203.370 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 16.972 | 79.319 | 51.285 | 33.884 | 175.931 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermalis By Dr Riciu S.r.l.